HomeInsightsStock Comparison

Lyka Labs Ltd vs Syncom Formulations India Ltd Stock Comparison

Lyka Labs Ltd vs Syncom Formulations India Ltd Stock Comparison

Last Updated on: Oct 08, 2025

Key Highlights

  • The Latest Trading Price of Lyka Labs Ltd is ₹ 95.39 as of 08 Oct 15:30.
  • The P/E Ratio of Lyka Labs Ltd changed from 10 on March 2022 to 45.1 on March 2025 . This represents a CAGR of 45.73% over 4 yearsThe P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 31 on March 2025 . This represents a CAGR of -9.49% over 4 years.
  • The Market Cap of Lyka Labs Ltd changed from ₹ 36.58 crore on March 2020 to ₹ 360.29 crore on March 2025 . This represents a CAGR of 46.41% over 6 yearsThe Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 1546 crore on March 2025 . This represents a CAGR of 13.96% over 4 years.
  • The revenue of Lyka Labs Ltd for the Jun '25 is ₹ 33.66 crore as compare to the Mar '25 revenue of ₹ 34.25 crore. This represent the decline of -1.72% The revenue of Syncom Formulations (India) Ltd for the Jun '25 is ₹ 122.98 crore as compare to the Mar '25 revenue of ₹ 155.83 crore. This represent the decline of -21.08%.
  • The ebitda of Lyka Labs Ltd for the Jun '25 is ₹ 4.32 crore as compare to the Mar '25 ebitda of ₹ 4.9 crore. This represent the decline of -11.84% The ebitda of Syncom Formulations (India) Ltd for the Jun '25 is ₹ 21.88 crore as compare to the Mar '25 ebitda of ₹ 24.7 crore. This represent the decline of -11.42%.
  • The net profit of Lyka Labs Ltd changed from ₹ -1.85 crore to ₹ 1 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Syncom Formulations (India) Ltd changed from ₹ 4.4 crore to ₹ 15.75 crore over 9 quarters. This represents a CAGR of 76.26% .
  • The Dividend Payout of Lyka Labs Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Lyka Labs Ltd

  • Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83.
  • It also added a range of ayurvedic and animal health care products over the years.
  • In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan.
  • Lyka Exports is the subsidiary of the company.
  • The Company is engaged in the business of pharmaceutical and related activities, including research. The company offers a broad range of antibiotics used as life-savers and to treat minor infections.

About Syncom Formulations (India) Ltd

  • Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.
  • The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
  • Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
  • Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

Lyka Labs Ltd News Hub

News

Lyka Labs to convene board meeting

Lyka Labs will hold a meeting of the Board of Directors of the Company on 29 September 202...

Read more

25 Sep 2025 09:58

News

Lyka Labs to discuss results

Lyka Labs will hold a meeting of the Board of Directors of the Company on 1 August 2025. P...

Read more

22 Jul 2025 10:53

News

Lyka Labs to conduct AGM

Lyka Labs announced that the 46th Annual General Meeting(AGM) of the company will be held ...

Read more

09 Jul 2025 10:25

News

Lyka Labs to discuss results

Lyka Labs will hold a meeting of the Board of Directors of the Company on 26 May 2025. Pow...

Read more

15 May 2025 11:52

News

Lyka Labs EGM scheduled

Lyka Labs announced that an Extra Ordinary General Meeting (EGM) of the Company will be he...

Read more

01 Feb 2025 13:50

News

Lyka Labs announces board meeting date

Lyka Labs will hold a meeting of the Board of Directors of the Company on 4 February 2025....

Read more

03 Jan 2025 09:46

Syncom Formulations (India) Ltd News Hub

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting(AGM) of the company ...

Read more

12 Aug 2025 12:18

News

Syncom Formulations (India) to table results

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

04 Aug 2025 11:23

News

Syncom Formulations (India) schedules board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

14 May 2025 14:06

News

Syncom Formulations (India) to convene board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

05 Nov 2024 14:12

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 17:48

News

Syncom Formulations (India) to hold AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 10:30

SWOT Analysis Of Lyka Labs Ltd

Strength

1

S

Weakness

4

W

Opportunity

1

O

Threats

1

T

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lyka Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Syncom Formulations (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Lyka Labs Ltd and Syncom Formulations (India) Ltd

Which company has a larger market capitalization, Lyka Labs Ltd or Syncom Formulations (India) Ltd?

Market cap of Lyka Labs Ltd is 340 Cr while Market cap of Syncom Formulations (India) Ltd is 1,608 Cr

What are the key factors driving the stock performance of Lyka Labs Ltd and Syncom Formulations (India) Ltd?

The stock performance of Lyka Labs Ltd and Syncom Formulations (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lyka Labs Ltd and Syncom Formulations (India) Ltd?

As of October 8, 2025, the Lyka Labs Ltd stock price is INR ₹95.39. On the other hand, Syncom Formulations (India) Ltd stock price is INR ₹17.11.

How do dividend payouts of Lyka Labs Ltd and Syncom Formulations (India) Ltd compare?

To compare the dividend payouts of Lyka Labs Ltd and Syncom Formulations (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions